UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER

Clinical trials for UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER explained in plain language.

Never miss a new study

Get alerted when new UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER trials appear

Sign up with your email to follow new studies for UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Major trial tests new hope for advanced colon cancer patients

Disease control Recruiting now

This study is testing whether a new drug called pumitamig, when added to standard chemotherapy, works better than the current standard treatment for advanced colorectal cancer. It will involve about 990 adults whose cancer has spread and cannot be removed by surgery, and who have…

Matched conditions: UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER

Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER

Get alerted when new UNTREATED, UNRESECTABLE, OR METASTATIC COLORECTAL CANCER trials appear

Major trial tests new hope for advanced colon cancer patients